MUCORMYCOTIC OSTEOMYELITIS-A CASE REPORT

Abstract

Mucormycosis, which is also known as phycomycotic or zygomycotic, is less frequent in the mouth. It is, yet, an aggressive, invasive, and potentially fatal fungal infection. It primarily targets people who have diabetes and altered immune system¹. The mutation causes the virus to continuously change its characteristics, such as virulence, pathogenicity, clinical symptoms, and the rate at which the disease spreads³. The disease usually progresses quickly, and diagnosis is frequently delayed, Life-saving surgical and medical intervention is necessary.² The fungal infection that typically affects the maxilla is also affecting those afflicted with the coronavirus illness 2019 (COVID-19) in this recent pandemic scenario¹. In this case study, we describe the unusual circumstance of a 48-year-old male who developed mucormycosis in his maxilla. The case report includes a brief review of the literature along with clinical findings, radiographic examinations, and histological information. Since mucormycosis is an aggressive fungal infection, treating it with a multimodal approach might lessen an individual's morbidity and mortality as well as systemic liability.